Whole body FDG-PET/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma

被引:21
作者
Wang Xiao-Xue [1 ]
Huang Xinyue [1 ]
Zhang Lijun [1 ]
机构
[1] China Med Univ, Hosp 1, Dept Hematol, Shenyang 110001, Peoples R China
来源
MEDICINA CLINICA | 2020年 / 154卷 / 02期
基金
中国国家自然科学基金;
关键词
Lymphoma; PET-CT; SUVmax; Bone marrow infiltration; Ann Arbor stage; B-CELL LYMPHOMA; F-18-FDG PET/CT; MALIGNANT-LYMPHOMA; HODGKIN-LYMPHOMA; BIOPSY; INVOLVEMENT; CT; DISEASE;
D O I
10.1016/j.medcli.2019.07.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Positron emission tomography-computed tomography (PET-CT) and bone marrow biopsy are currently the common clinical examination of lymphoma infiltration. The aim of this research is to evaluate the value of PET-CT in diagnosis of bone marrow infiltration, clinical staging and pathological typing of lymphoma. Methods: 153 cases were analyzed retrospectively to compare the consistency of PET-CT and bone marrow biopsy. We analyzed the sensitivity, accuracy and specificity of PET-CT in different clinical pathology of lymphoma. Results: The PET-CT sensitivity in detecting bone marrow infiltration is 54.3% with a specificity of 80.5% and accuracy of 74.5%. In aggressive B-cell lymphoma (DLBCL, HG-BL) and MZL, PET-CT results of bone marrow infiltration showed high accuracy of 88.1% and 83.3% respectively. The median value of SUVmax in the patients detected to have bone marrow infiltration by BMB was significantly higher than patients with BMB negative results among subgroups of aggressive B-cell lymphoma, MZL and T-NHL (p<.05). Conclusion: PET-CT is significant in detecting bone marrow infiltration in certain pathological types of lymphoma. However pathological inconsistencies still exist between bone marrow biopsy and PET-CT, thus PET-CT cannot completely replace biopsy. (C) 2019 The Authors. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:61 / 65
页数:5
相关论文
共 50 条
  • [21] Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams, Hugo J. A.
    Kwee, Thomas C.
    Fijnheer, Rob
    Dubois, Steven V.
    Nievelstein, Rutger A. J.
    de Klerk, John M. H.
    ANNALS OF NUCLEAR MEDICINE, 2015, 29 (02) : 132 - 137
  • [22] Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma
    Badr, Salma
    Kotb, Magdy
    Elahmadawy, Mai Amr
    Moustafa, Hosna
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (12) : E428 - E438
  • [23] Overestimated value of FDG-PET based bone marrow evaluation in lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (02) : 336 - 337
  • [24] Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma
    Adams, Hugo J. A.
    Nievelstein, Rutger A. J.
    Kwee, Thomas C.
    BLOOD REVIEWS, 2015, 29 (06) : 417 - 425
  • [25] Comparison of Bone Marrow Involvement with Bone Marrow Biopsy and PET-CT and Evaluation of Any Effects on Survival in Patients Diagnosed with Hodgkin and Non-Hodgkin Lymphoma
    Gocer, Mesut
    Kurtoglu, Erdal
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2021, 37 (01) : 52 - 59
  • [26] [18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients
    Mayerhoefer, Marius E.
    Riedl, Christopher C.
    Kumar, Anita
    Dogan, Ahmet
    Gibbs, Peter
    Weber, Michael
    Staber, Philipp B.
    Castellanos, Sandra Huicochea
    Schoeder, Heiko
    CANCERS, 2020, 12 (05)
  • [27] Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT
    Weiler-Sagie, Michal
    Kagna, Olga
    Dann, Eldad J.
    Ben-Barak, Ayelet
    Israel, Ora
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (06) : 1133 - 1140
  • [28] 18F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma
    Ujjani, Chaitra S.
    Hill, Elizabeth M.
    Wang, Hongkun
    Nassif, Samer
    Esposito, Giuseppe
    Ozdemirli, Metin
    Cordova, Christine
    Cheson, Bruce D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (03) : 410 - 416
  • [29] Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients
    Abdulqadhr, Goran
    Molin, Daniel
    Astrom, Gunnar
    Suurkula, Madis
    Johansson, Lars
    Hagberg, Hans
    Ahlstrom, Hakan
    ACTA RADIOLOGICA, 2011, 52 (02) : 173 - 180
  • [30] Is MRI less accurate than FDG-PET/CT in diagnosing bone marrow involvement in lymphoma?
    Kwee, Thomas C.
    Nievelstein, Rutger A. J.
    EUROPEAN JOURNAL OF RADIOLOGY, 2011, 80 (02) : 565 - 566